Skip to contentSkip to footer
employer cover photo
employer logo
employer logo

U.S. Pharmacopeia

Engaged Employer

U.S. Pharmacopeia reviews

2.7

40% would recommend to a friend

(338 total reviews)
avatar

Ronald T Piervincenzi

45% approve of CEO

37% positive business outlook

Ratings by category

3.5

Work/Life balance

3.4

Compensation and benefits

3.2

Diversity & inclusion

2.9

Culture & values

2.4

Senior management

2.3

Career opportunities

U.S. Pharmacopeia has an employee rating of 2.7 out of 5 stars, based on 338 company reviews on Glassdoor which indicates that most employees have an average working experience there. The U.S. Pharmacopeia employee rating is 22% below average for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).

Ratings by demographic groups

Reviews by job title

338 reviews
1.0
Mar 25, 2026

USP is headed straight into a brick wall at the speed of lightning

Manager
Recommend
CEO approval
Business Outlook

Pros

Somewhat decent benefits, hybrid work model

Cons

On-site requirement 3 days out of the week, limited opportunities for advancement, a bunch of talk but no follow through or follow-up, mass layoffs and high turnover, reactive instead of proactive, jobs being sent to India, too much money being spent on acquiring new businesses with no return on the investment and at the expense of employees.

avatar
U.S. Pharmacopeia Response
3mo
We’d like to address the concerns raised in your review directly. First, claims of layoffs at USP are inaccurate. While we periodically review our structure to ensure we are aligned with strategic and operational needs, something any responsible organization does, there are presently no organization-wide layoffs at USP. Decisions affecting positions are made thoughtfully, communicated clearly, and with a focus on long-term sustainability, not fear-based management. USP operates as a global scientific organization, and our presence in India and other regions reflects where the pharmaceutical manufacturing ecosystem exists today. This global footprint is essential to supporting our mission and ensuring continuity and resilience, not a dismissal of our U.S. workforce. In fact, we continue to invest significantly in our U.S. operations, capabilities, and people. We recognize that hybrid work expectations, perceptions about the pace of decision-making, and advancement can be sources of frustration. These are areas we continue to evaluate and improve through clearer role definition, leadership development, and more structured talent and succession planning. Assertions that leadership or the Board of Trustees is unaware of organizational realities are also incorrect. USP’s governance includes robust oversight, regular performance reviews, and active engagement with management on strategy, financial health, and workforce considerations. We provide multiple avenues for employees to raise concerns, including managers, HR Business Partners, Employee Relations, Compliance & Ethics, and our confidential Speak Up line. We recognize that individual experiences can vary, and we regret that yours was not positive. Best of luck to you in your next chapter.
1.0
Mar 24, 2026

Run.

Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Benefits. Otherwise, none that I can think of.

Cons

Too many... All about optics. Transactional and superficial behavior running amok. Job description not accurate. Many hostile, cold, unfriendly people. A lot of these 5 star reviews are obviously HR-planted with use of AI to write them. The USP rating is realistically lower than what you see now... Scary.

avatar
U.S. Pharmacopeia Response
3mo
We’re sorry to hear that your experience at USP led to this perception. We take feedback seriously, including critical perspectives shared on Glassdoor. To be clear, USP does not discourage employees from using Glassdoor, nor do we plant or script reviews. Glassdoor is one of several ways current and former employees choose to share their views, and individual experiences can vary widely across teams, roles, and time periods. For employees within the organization, we also provide multiple internal channels to share feedback or raise concerns directly, including managers, HR Business Partners, Employee Relations, Compliance & Ethics, and our confidential Speak Up line. These avenues exist to ensure concerns can be heard, explored, and addressed appropriately. We regret that this was not a positive chapter for you and wish you well moving forward.
1.0
Mar 15, 2026

Dysfunction dressed up in corporate values

Director
Recommend
CEO approval
Business Outlook

Pros

There are talented people here, and some teams genuinely try to do good work. The mission sounds compelling on paper.

Cons

Where to start. The DEI program became so overzealous that it stopped being about inclusion and started being about optics and box-checking. Decisions — including hiring, promotions, and project assignments — visibly prioritized optics over merit and competence. Morale among high performers eroded fast. Layoffs were handled poorly and repeatedly. Leadership would announce "we're in a great position" and then cut 10-15% of staff months later. This cycle happened more than once. No accountability, no transparency, just a new all-hands with fresh talking points. Turnover was relentless. Good people left constantly, and leadership either didn't notice or didn't care. Institutional knowledge walked out the door while management patted itself on the back. The infighting between business units was exhausting. Competing priorities, duplicated efforts, and zero alignment from the top. Cross-functional work felt like trench warfare.

avatar
U.S. Pharmacopeia Response
3mo
We’re disappointed to hear that your experience at USP led to these conclusions, especially given your long tenure with the organization. We want to address a few points directly. First, assertions of repeated large-scale layoffs are not accurate. While USP has periodically made focused organizational adjustments, we have not conducted ongoing or cyclical reductions at the scale described. When role changes do occur, they are tied to business priorities and communicated with care, not as a contradiction to our overall organizational health. With respect to DEI, USP is proud of a merit-based culture that values expertise, performance, and integrity. Our inclusion efforts are intended to ensure that all qualified individuals, regardless of background or perspective, have equitable access to opportunities and are treated with respect. Hiring, advancement, and project assignments are based on role requirements, skills, and experience, not “optics.” Encouraging diverse viewpoints strengthens scientific rigor and decision-making and is not at odds with high performance. We regret that this was not your experience and appreciate your sharing your perspective. We wish you the best in your future endeavors.
Viewing 4 - 6 of 338 Reviews
Related searches: U.S. Pharmacopeia jobs | U.S. Pharmacopeia salaries | U.S. Pharmacopeia benefits | U.S. Pharmacopeia interviews
ReviewsU.S. Pharmacopeia reviews

Glassdoor has 373 U.S. Pharmacopeia reviews submitted anonymously by U.S. Pharmacopeia employees. Read employee reviews and ratings on Glassdoor to decide if U.S. Pharmacopeia is right for you.